Wire Stories
-
656Expert Seminar on Anti-COVID-19 Chinese Herbal Medicine �Honee Taishen Granule� Held in Ritan, Beijing
BEIJING–(BUSINESS WIRE)–On November 26, 2020, Beijing Handian Pharmaceutical held an expert seminar on anti-COVID-19 medicine �Honee Taishen Granule� in Ritan, Beijing. At...
-
660
SUSMED Brings Greater Efficiencies in Clinical Trials by Using Blockchain Technology
Deregulations with Remarkable Results from a Regulatory Sandbox TOKYO–(BUSINESS WIRE)–SUSMED, Inc., has announced that it has received word from both the Ministers...
-
648
Lianhua Qingwen Capsules Obtained Approval in the Philippines
SHIJIAZHUANG CITY, China–(BUSINESS WIRE)–Lianhua Qingwen Capsules, a Chinese traditional medicine produced by Yiling Pharmaceutical, has been approved by the Food and Drug...
-
640
Mitsubishi Electric Launches u series Escalator
Enhanced passenger safety and comfort, significant energy savings and reduced environmental impact TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO:6503) announced today the immediate commercial...
-
1.1K
Toyama Prefectural Museum of Art and Design: The Only Poster Exhibition in Japan Opens to International Entries
The 13th International Poster Triennial in Toyama 2021 Deadline for entries extended to February 28, 2021 TOYAMA, Japan–(BUSINESS WIRE)–Toyama Prefectural Museum of...
-
745
Jefferies Announces Co-Brand Alliance with KB Securities in South Korea
NEW YORK & HONG KONG & LONDON & SEOUL–(BUSINESS WIRE)–Jefferies today announced that it has established a co-brand alliance with KB Securities...
-
651
Sinovac Secures Approximately $500 Million in Funding for COVID-19 Vaccine Development
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (�Sinovac� or the �Company�) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that Sinovac...
-
677
GenesisCare Clinical CRO Adopts Veeva Vault Clinical Applications to Accelerate and Scale Studies Globally
Leading CRO using Veeva Vault eTMF, Veeva Vault CTMS, and Veeva Vault Payments to streamline clinical trial processes SYDNEY–(BUSINESS WIRE)–Veeva Systems (NYSE:...
-
660
BeiGene Announces Data on BRUKINSA� (Zanubrutinib) from Phase 2 Trial in Marginal Zone Lymphoma and Phase 3 Trial in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma at the 62nd ASH Annual Meeting
Zanubrutinib was shown to be highly active in patients with relapsed/refractory marginal zone lymphoma in initial results from the Phase 2 MAGNOLIA...
-
682
The 3rd Hainan Island International Film Festival opened in Sanya, Hainan, China
SANYA, Hainan, China–(BUSINESS WIRE)–On December 5th, the 3rd Hainan Island International Film Festival opened in Sanya, Hainan, China. Shen Xiaoming, secretary of...
